NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Dow Inc. ("Dow" or the "Company") (NYSE:DOW) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?Do you, or did you, own shares of Dow Inc. (NYSE: DOW)?Did you purchase your shares between January 30, 2025 and July 23, 2025, ...
ACCESSWIRE
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds V.F. Corporation ("VFC" or the "Company") (NYSE:VFC) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.Should You Join This Class Action Lawsuit?Do you, or did you, own shares of V.F. Corporation (NYSE: VFC)?Did you purchase your shares between October 30, 2023 and May 20, 2025, ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. ("Semler" or the "Company") (NASDAQ:SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08010, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against VF Corporation ("VFC" or the "Company") (NYSE:VFC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ:NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv- 03999, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nutex ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fortinet, Inc. ("Fortinet" or the "Company") (NASDAQ:FTNT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Freshpet, Inc. ("Freshpet" or the "Company") (NASDAQ:FRPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Freshpet and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for information ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc ("Marex" or the "Company") (NASDAQ:MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against WPP Plc ("WPP" or the "Company") (NYSE:WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ:ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of CarMax, Inc. ("CarMax" or the "Company") (NYSE:KMX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether CarMax and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for information about ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE:MOH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Braskem S.A. ("Braskem" or the "Company") (NYSE:BAK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Braskem and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for information about joining ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ:MLTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Moonlake and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. ("Skye" or the "Company") (NASDAQ:SKYE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Skye and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for information ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc.("Organogenesis" or the "Company") (NASDAQ:ORGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Organogenesis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Informatica Inc. ("Informatica" or the "Company") (NYSE:INFA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Informatica and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fortress Biotech Inc. ("Fortress" or the "Company") (NASDAQ:FBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Fortress and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ:TNDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Tandem and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for information ...